NDC 44911-0097

Psorinum

Psorinum

Psorinum is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Scabies Lesion Lysate (human).

Product ID44911-0097_0e27dae5-db51-4f1a-b12c-c3d8b3576a11
NDC44911-0097
Product TypeHuman Prescription Drug
Proprietary NamePsorinum
Generic NamePsorinum
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2014-12-09
Marketing End Date2025-09-22
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameEnergique, Inc.
Substance NameSCABIES LESION LYSATE (HUMAN)
Active Ingredient Strength7 [hp_X]/mL
NDC Exclude FlagN

Packaging

NDC 44911-0097-1

30 mL in 1 PACKAGE (44911-0097-1)
Marketing Start Date2014-12-09
Marketing End Date2025-09-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44911-0097-1 [44911009701]

Psorinum LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-09
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SCABIES LESION LYSATE (HUMAN)7 [hp_X]/mL

OpenFDA Data

SPL SET ID:fe712217-e56d-49f7-a791-0351f5e61896
Manufacturer
UNII

NDC Crossover Matching brand name "Psorinum" or generic name "Psorinum"

NDCBrand NameGeneric Name
0220-7604PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7622PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7623PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7624PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7625PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7626PsorinumSCABIES LESION LYSATE (HUMAN)
44911-0097PsorinumPsorinum
62106-6903PSORINUMPsorinum
64117-407PSORINUMSCABIES LESION LYSATE (HUMAN)
69152-1204Psorinum 1MPsorinum
69152-1006Psorinum 200CPsorinum

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.